Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Vocabulary and Main Idea Reading Intervention Using Text Choice to Improve Content Knowledge and Reading Comprehension of Adolescents With Autism Spectrum Disorder.

Solis M, Reutebuch CK, Falcomata T, Steinle PK, Miller VL, Vaughn S.

Behav Modif. 2019 Jun 10:145445519853781. doi: 10.1177/0145445519853781. [Epub ahead of print]

PMID:
31177808
2.

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis.

Quinn JD, Weening EH, Miner TA, Miller VL.

J Bacteriol. 2019 Jul 24;201(16). pii: e00217-19. doi: 10.1128/JB.00217-19. Print 2019 Aug 15.

3.

A Klebsiella pneumoniae Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity.

Walker KA, Miner TA, Palacios M, Trzilova D, Frederick DR, Broberg CA, SepĂșlveda VE, Quinn JD, Miller VL.

MBio. 2019 Mar 26;10(2). pii: e00089-19. doi: 10.1128/mBio.00089-19.

4.

The Evolution of SlyA/RovA Transcription Factors from Repressors to Countersilencers in Enterobacteriaceae.

Will WR, Brzovic P, Le Trong I, Stenkamp RE, Lawrenz MB, Karlinsey JE, Navarre WW, Main-Hester K, Miller VL, Libby SJ, Fang FC.

MBio. 2019 Mar 5;10(2). pii: e00009-19. doi: 10.1128/mBio.00009-19.

5.

Analysis of novel domain-specific mutations in the zebrafish ndr2/cyclops gene generated using CRISPR-Cas9 RNPs.

Turner AN, Andersen RS, Bookout IE, Brashear LN, Davis JC, Gahan DM, Davis JC, Gotham JP, Hijaz BA, Kaushik AS, Mcgill JB, Miller VL, Moseley ZP, Nowell CL, Patel RK, Rodgers MC, Patel RK, Shihab YA, Walker AP, Glover SR, Foster SD, Challa AK.

J Genet. 2018 Dec;97(5):1315-1325.

6.

Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains.

Palacios M, Miner TA, Frederick DR, Sepulveda VE, Quinn JD, Walker KA, Miller VL.

MBio. 2018 Aug 7;9(4). pii: e01443-18. doi: 10.1128/mBio.01443-18.

7.

A Serendipitous Mutation Reveals the Severe Virulence Defect of a Klebsiella pneumoniae fepB Mutant.

Palacios M, Broberg CA, Walker KA, Miller VL.

mSphere. 2017 Aug 23;2(4). pii: e00341-17. doi: 10.1128/mSphere.00341-17. eCollection 2017 Jul-Aug.

8.

Preparing Postbaccalaureates for Entry and Success in Biomedical PhD Programs.

Hall JD, Harrell JR, Cohen KW, Miller VL, Phelps PV, Cook JG.

CBE Life Sci Educ. 2016 fall;15(3). pii: ar27. doi: 10.1187/cbe.16-01-0054.

9.

The YsrS Paralog DygS Has the Capacity To Activate Expression of the Yersinia enterocolitica Ysa Type III Secretion System.

Walker KA, Griggs LA, Obrist M, Bode A, Summers RP, Miller VL.

J Bacteriol. 2016 May 27;198(12):1725-1734. doi: 10.1128/JB.00240-16. Print 2016 Jun 15.

10.

A Deadly Path: Bacterial Spread During Bubonic Plague.

Gonzalez RJ, Miller VL.

Trends Microbiol. 2016 Apr;24(4):239-241. doi: 10.1016/j.tim.2016.01.010. Epub 2016 Feb 12.

11.

Comparison of Models for Bubonic Plague Reveals Unique Pathogen Adaptations to the Dermis.

Gonzalez RJ, Weening EH, Lane MC, Miller VL.

Infect Immun. 2015 Jul;83(7):2855-61. doi: 10.1128/IAI.00140-15. Epub 2015 May 4.

12.

In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation.

Pechous RD, Broberg CA, Stasulli NM, Miller VL, Goldman WE.

MBio. 2015 Feb 17;6(1):e02302-14. doi: 10.1128/mBio.02302-14.

13.

Dissemination of a highly virulent pathogen: tracking the early events that define infection.

Gonzalez RJ, Lane MC, Wagner NJ, Weening EH, Miller VL.

PLoS Pathog. 2015 Jan 22;11(1):e1004587. doi: 10.1371/journal.ppat.1004587. eCollection 2015 Jan.

14.

Complete Genome Sequence of Klebsiella pneumoniae Strain ATCC 43816 KPPR1, a Rifampin-Resistant Mutant Commonly Used in Animal, Genetic, and Molecular Biology Studies.

Broberg CA, Wu W, Cavalcoli JD, Miller VL, Bachman MA.

Genome Announc. 2014 Sep 25;2(5). pii: e00924-14. doi: 10.1128/genomeA.00924-14.

15.

Klebsiella: a long way to go towards understanding this enigmatic jet-setter.

Broberg CA, Palacios M, Miller VL.

F1000Prime Rep. 2014 Aug 1;6:64. doi: 10.12703/P6-64. eCollection 2014. Review.

16.

YaxAB, a Yersinia enterocolitica pore-forming toxin regulated by RovA.

Wagner NJ, Lin CP, Borst LB, Miller VL.

Infect Immun. 2013 Nov;81(11):4208-19. doi: 10.1128/IAI.00781-13. Epub 2013 Sep 3.

17.

Whole-Genome Draft Sequences of Three Multidrug-Resistant Klebsiella pneumoniae Strains Available from the American Type Culture Collection.

Broberg CA, Palacios M, Miller VL.

Genome Announc. 2013 May 30;1(3). pii: e00312-13. doi: 10.1128/genomeA.00312-13.

18.

Acquisition of omptin reveals cryptic virulence function of autotransporter YapE in Yersinia pestis.

Lawrenz MB, Pennington J, Miller VL.

Mol Microbiol. 2013 Jul;89(2):276-87. doi: 10.1111/mmi.12273. Epub 2013 Jun 10.

19.

Proteolytic processing of the Yersinia pestis YapG autotransporter by the omptin protease Pla and the contribution of YapG to murine plague pathogenesis.

Lane MC, Lenz JD, Miller VL.

J Med Microbiol. 2013 Aug;62(Pt 8):1124-34. doi: 10.1099/jmm.0.056275-0. Epub 2013 May 8.

20.

A phenotype at last: essential role for the Yersinia enterocolitica Ysa type III secretion system in a Drosophila melanogaster S2 cell model.

Walker KA, Maltez VI, Hall JD, Vitko NP, Miller VL.

Infect Immun. 2013 Jul;81(7):2478-87. doi: 10.1128/IAI.01454-12. Epub 2013 Apr 29.

21.

The clinical case for proton beam therapy.

Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB.

Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174. Review.

22.

Bioluminescence imaging to track bacterial dissemination of Yersinia pestis using different routes of infection in mice.

Gonzalez RJ, Weening EH, Frothingham R, Sempowski GD, Miller VL.

BMC Microbiol. 2012 Jul 24;12:147. doi: 10.1186/1471-2180-12-147.

23.

Evolution and virulence contributions of the autotransporter proteins YapJ and YapK of Yersinia pestis CO92 and their homologs in Y. pseudotuberculosis IP32953.

Lenz JD, Temple BR, Miller VL.

Infect Immun. 2012 Oct;80(10):3693-705. doi: 10.1128/IAI.00529-12. Epub 2012 Jul 16.

24.

Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.

Miller VL, Lin HK, Murugan P, Fan M, Penning TM, Brame LS, Yang Q, Fung KM.

Int J Clin Exp Pathol. 2012;5(4):278-89. Epub 2012 Apr 26.

25.

Low copy expression vectors for use in Yersinia sp. and related organisms.

Obrist MW, Miller VL.

Plasmid. 2012 Jul;68(1):33-42. doi: 10.1016/j.plasmid.2012.02.003. Epub 2012 Mar 15.

26.

Expression during host infection and localization of Yersinia pestis autotransporter proteins.

Lenz JD, Lawrenz MB, Cotter DG, Lane MC, Gonzalez RJ, Palacios M, Miller VL.

J Bacteriol. 2011 Nov;193(21):5936-49. doi: 10.1128/JB.05877-11. Epub 2011 Aug 26.

27.

Influence of combinatorial histone modifications on antibody and effector protein recognition.

Fuchs SM, Krajewski K, Baker RW, Miller VL, Strahl BD.

Curr Biol. 2011 Jan 11;21(1):53-8. doi: 10.1016/j.cub.2010.11.058. Epub 2010 Dec 17.

28.

The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background.

Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, Goldman WE, Miller VL.

Infect Immun. 2011 Feb;79(2):644-52. doi: 10.1128/IAI.00981-10. Epub 2010 Nov 29.

29.

Identification of YsrT and evidence that YsrRST constitute a unique phosphorelay system in Yersinia enterocolitica.

Walker KA, Obrist MW, Mildiner-Earley S, Miller VL.

J Bacteriol. 2010 Nov;192(22):5887-97. doi: 10.1128/JB.00745-10. Epub 2010 Sep 24.

30.

Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.

Bachman MA, Miller VL, Weiser JN.

PLoS Pathog. 2009 Oct;5(10):e1000622. doi: 10.1371/journal.ppat.1000622. Epub 2009 Oct 16.

31.

Synchronous gene expression of the Yersinia enterocolitica Ysa type III secretion system and its effectors.

Walker KA, Miller VL.

J Bacteriol. 2009 Mar;191(6):1816-26. doi: 10.1128/JB.01402-08. Epub 2009 Jan 5.

32.

A novel autotransporter adhesin is required for efficient colonization during bubonic plague.

Lawrenz MB, Lenz JD, Miller VL.

Infect Immun. 2009 Jan;77(1):317-26. doi: 10.1128/IAI.01206-08. Epub 2008 Oct 20.

33.

YspM, a newly identified Ysa type III secreted protein of Yersinia enterocolitica.

Witowski SE, Walker KA, Miller VL.

J Bacteriol. 2008 Nov;190(22):7315-25. doi: 10.1128/JB.00861-08. Epub 2008 Sep 19.

34.

The Human Genome Project: implications for families.

Miller VL, Martin AM.

Health Soc Work. 2008 Feb;33(1):73-6. No abstract available.

PMID:
18326452
35.

Environmental stimuli affecting expression of the Ysa type three secretion locus.

Mildiner-Earley S, Walker KA, Miller VL.

Adv Exp Med Biol. 2007;603:211-6.

PMID:
17966417
36.
37.

Comparative analysis of the regulation of rovA from the pathogenic yersiniae.

Lawrenz MB, Miller VL.

J Bacteriol. 2007 Aug;189(16):5963-75. Epub 2007 Jun 15.

38.

Herpesvirus latency confers symbiotic protection from bacterial infection.

Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW 4th.

Nature. 2007 May 17;447(7142):326-9.

PMID:
17507983
40.

A plasminogen-activating protease specifically controls the development of primary pneumonic plague.

Lathem WW, Price PA, Miller VL, Goldman WE.

Science. 2007 Jan 26;315(5811):509-13.

41.

Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection.

Lawlor MS, O'connor C, Miller VL.

Infect Immun. 2007 Mar;75(3):1463-72. Epub 2007 Jan 12.

42.
43.

RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague.

Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL.

Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13514-9. Epub 2006 Aug 28.

44.

Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections.

Lawlor MS, Handley SA, Miller VL.

Infect Immun. 2006 Sep;74(9):5402-7.

45.
46.

Characterization of a novel porin involved in systemic Yersinia enterocolitica infection.

Mildiner-Earley S, Miller VL.

Infect Immun. 2006 Jul;74(7):4361-5.

47.

Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection.

Handley SA, Dube PH, Miller VL.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9268-73. Epub 2006 May 22.

48.

Regulation of virulence by members of the MarR/SlyA family.

Ellison DW, Miller VL.

Curr Opin Microbiol. 2006 Apr;9(2):153-9. Epub 2006 Mar 10. Review.

PMID:
16529980
49.

Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity.

Lathem WW, Crosby SD, Miller VL, Goldman WE.

Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91. Epub 2005 Nov 23.

50.

Supplemental Content

Loading ...
Support Center